Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
28. März 2024 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 28, 2024 (GLOBE NEWSWIRE) -- Endonovo (OTC PINK: ENDV) and its subsidiary, SofPulse, Inc., today announced they have finalized and completed the Asset Purchase Agreement...
Endonovo's SofPulse® Secures Taiwan FDA Approval
12. Oktober 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) US-based medical device company, today announced the full regulatory approval of its flagship product,...
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
22. August 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a US-based commercial medical device company -- today announced its inclusion on the Federal Supply...
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
08. August 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) -- commercial developer of medical technology-- is proud to announce a series of advancements in the first...
Endonovo Pending Agreement to Develop Telehealth Division
07. Juni 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, June 07, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), an industry leading medical technology company, is working with a prominent developer of telehealth...
Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies
25. April 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 25, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a leading developer of medical technologies, today announced it is moving forward in its clinical...
Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman
13. April 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 13, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a commercial stage developer of non-invasive medical devices, is pleased to announce its partnership...
Endonovo Announces Partnership with Santana Lead Singer Andy Vargas
10. April 2023 12:01 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 10, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc (OTCQB: ENDV) -- a pioneer in bioelectronic medical devices -- announced today its partnership with world-renowned...
Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company
29. März 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 29, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced a binding Letter of Intent (LOI) to spin off its current medical device division to an...
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan
23. März 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 23, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a medical device company known for its innovative and effective pain management solutions --...